#LungCancerTreatment
LightNews LightNews
amitsingh121.bsky.social
Advanced Lung Cancer Treatment in #Varanasi: Understanding the Causes, Key Symptoms, and Modern Care Options tinyurl.com/53ku424c

#LungCancerTreatment #SwapnilPatel #CancerSurgeon
November 29, 2025 at 2:43 AM
seldon-dengyue.bsky.social
💊 Glecirasib Citrate Tablets—now approved in China!
🎯 Targets KRAS G12C–mutated advanced NSCLC

📎 Learn more: dengyuemed.com/product/airu...
📧 [email protected]

#GlecirasibCitrateTablets #Allist #KRASG12C #KRAS #KRASInhibitor #NSCLC #LungCancerTreatment
#HongKongDengYueMedicine
November 14, 2025 at 7:03 AM
med-news.bsky.social
Lung cancer is the leading killer in Nebraska. In 2025, state projections estimate 1,260 new diagnoses and 720 deaths due to the disease. CHI Health

buff.ly/rZYRSdA

#MED #CHIHealth #LungCancerScreening #LungCancerTreatment
October 23, 2025 at 4:08 PM
iaslc.bsky.social
FDA grants accelerated approval to datopotamab deruxtecan-dlnk for EGFR-mutated non-small cell lung cancer.

Learn more ➡️ bit.ly/44fIz4B

#FDAApproval #AcceleratedApproval #OncologyNews
#LungCancerTreatment #CancerResearch
FDA grants accelerated approval to datopotamab deruxtecan-dlnk
On June 23, 2025, the Food and Drug Administration granted accelerated approval to datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo, Inc.).
bit.ly
June 26, 2025 at 9:25 PM
uchicagocancer.bsky.social
Drs. Choudhury & Garassino have a great new paper out in The Lancet about the importance of the maintenance phase of treatment in extensive-stage small-cell lung cancer! You can read it at www.thelancet.com/journals/lan...

#lungcancer #lungcancertreatment #OncSky
Lurbinectedin with atezolizumab maintenance therapy in extensive-stage small-cell lung cancer
Small-cell lung cancer (SCLC) is one of the most lethal cancers, with patients diagnosed with extensive-stage small-cell lung cancer (ES-SCLC) experiencing a median survival of just 12 months after st...
www.thelancet.com
June 13, 2025 at 6:13 PM
bionewscentral.com
Results from a phase 3 #ClinicalTrial show that combining #immunotherapy with #chemotherapy before #LungCancerSurgery lowers the risk of #CancerRecurrence and increases long-term #survival. 
#NonSmallCellLungCancer #NSCLC #LungCancerTreatment
Immunotherapy before surgery improves lung cancer survival – BioNews Central
Results from a phase 3 clinical trial show that combining immunotherapy with chemotherapy before lung cancer surgery lowers the risk of cancer recurrence and increases long-term survival. ...
sbee.link
June 2, 2025 at 5:35 PM
choosesjc.bsky.social
“We have the ability to travel further into the lungs than ever before... The kind of detail we can see now enables us to identify small tumors when they are most treatable.” More at www.sjchs.org/smart-living...
#lungcancer #cancer #cancercenter #lungcancertreatment #oncology
April 21, 2025 at 6:06 PM
4040rec.bsky.social
#oncology #Amivantamab #lazertinib #lungcancer #Janssen #phase3clinicaltrial #MARIPOSAstudy #EGFRmutatedadvancednonsmallcelllungcancer #NSCLC #nonsmallcelllungcancer #Rybrevant #Lazcluze #EuropeanLungCancerCongress #lungcancertreatment #patientoutcomes
pharmatimes.com/news/amivant...
Amivantamab plus lazertinib shows survival benefit in lung cancer - PharmaTimes
Janssen drug combination extends life expectancy during trial
pharmatimes.com
April 1, 2025 at 9:46 AM
lungcancerlcfa.bsky.social
Speakers Bureau member Lysa Buonanno is accessing tomorrow’s treatments today through clinical trials. Learn more about clinical trials in the link: https://buff.ly/40OIa7G

#ClinicalTrials #LungCancerTreatment
February 9, 2025 at 7:15 PM
4040rec.bsky.social
#oncology #lungcancer @amgen.bsky.social #lungcancertreatment #IMDYLLTRA #tarlatamab #extensivestagesmallcelllungcancer #ESSCLC #ESSCLCpatients #UK #MHRA #conditionalmarketingauthorisation #Smallcelllungcancer #SCLC #DeLLphi301study #objectiveresponserate
pharmatimes.com/news/amgens-...
Amgen’s lung cancer treatment gets conditional approval - PharmaTimes
IMDYLLTRA offers new hope for patients with extensive-stage small cell lung cancer
pharmatimes.com
January 7, 2025 at 10:10 AM
4040rec.bsky.social
#oncology #Imfinzi #durvalumab #AstraZeneca #NICErecommendation #lungcancer #lungcancerpatients #lungcancertreatment #resectablenonsmallcelllungcancer #NSCLC #AEGEANphase3trial #NHS #NSCLCpatients #ThoracicOncology #patientoutcomes #AEGEANtrial
pharmatimes.com/news/imfinzi...
Imfinzi receives NICE recommendation for lung cancer treatment - PharmaTimes
Trial results lead to new treatment option for lung cancer
pharmatimes.com
December 10, 2024 at 11:39 AM
cancergrace.bsky.social
肺癌治疗中的获得性耐药 - East Asian LCVL 2024 youtu.be/gFrAC3p97do?... via @YouTube
帕蒂尔博士讨论了肺癌治疗中的获得性耐药问题，以及肿瘤学家希望如何解决这个问题。
For more, please visit cancergrace.org. To join the conversation, visit cancergrace.org/forum.
#LungCancer #MandarinLungCancerVideo #lungcancertreatment
肺癌治疗中的获得性耐药 - East Asian LCVL 2024
YouTube video by GRACE - Global Resource for Advancing Cancer Education
youtu.be
August 19, 2024 at 5:45 PM